146 related articles for article (PubMed ID: 19640273)
21. Polymorphisms associated with circulating sex hormone levels in postmenopausal women.
Dunning AM; Dowsett M; Healey CS; Tee L; Luben RN; Folkerd E; Novik KL; Kelemen L; Ogata S; Pharoah PD; Easton DF; Day NE; Ponder BA
J Natl Cancer Inst; 2004 Jun; 96(12):936-45. PubMed ID: 15199113
[TBL] [Abstract][Full Text] [Related]
22. Gonadotropin-releasing hormone neuropeptides and receptor in human breast cancer: correlation to poor prognosis parameters.
Pazaitou-Panayiotou K; Chemonidou C; Poupi A; Koureta M; Kaprara A; Lambropoulou M; Constantinidis TC; Galaktidou G; Koffa M; Kiziridou A; Kakolyris S; Kolios G; Kortsaris A; Chatzaki E
Peptides; 2013 Apr; 42():15-24. PubMed ID: 23287110
[TBL] [Abstract][Full Text] [Related]
23. The genes for gonadotropin-releasing hormone and its receptor are expressed in human breast with fibrocystic disease and cancer.
Kottler ML; Starzec A; Carre MC; Lagarde JP; Martin A; Counis R
Int J Cancer; 1997 May; 71(4):595-9. PubMed ID: 9178813
[TBL] [Abstract][Full Text] [Related]
24. Effects of MboII and BspMI polymorphisms in the gonadotropin releasing hormone receptor (GnRHR) gene on sperm quality in Holstein bulls.
Yang WC; Tang KQ; Yu JN; Zhang CY; Zhang XX; Yang LG
Mol Biol Rep; 2011 Jun; 38(5):3411-5. PubMed ID: 21104139
[TBL] [Abstract][Full Text] [Related]
25. Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort.
Haiman CA; Garcia RR; Hsu C; Xia L; Ha H; Sheng X; Le Marchand L; Kolonel LN; Henderson BE; Stallcup MR; Greene GL; Press MF
BMC Cancer; 2009 Jan; 9():43. PubMed ID: 19183483
[TBL] [Abstract][Full Text] [Related]
26. Polymorphism identification in goat GNRH1 and GDF9 genes and their association analysis with litter size.
An XP; Hou JX; Zhao HB; Li G; Bai L; Peng JY; M Yan Q; Song YX; Wang JG; Cao BY
Anim Genet; 2013 Apr; 44(2):234-8. PubMed ID: 22812579
[TBL] [Abstract][Full Text] [Related]
27. Multiplex ligation dependent probe amplification analysis of KAL1, GNRH1, GNRHR, PROK2 and PROKR2 in male patients with idiopathic hypogonadotropic hypogonadism.
Basaran Y; Bolu E; Unal HU; Sagkan RI; Taslipinar A; Ozgurtas T; Musabak U
Endokrynol Pol; 2013; 64(4):285-92. PubMed ID: 24002956
[TBL] [Abstract][Full Text] [Related]
28. Association between
Weng SL; Tzeng SL; Lee CI; Liu CH; Huang CC; Yang SF; Lee MS; Lee TH
Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34209056
[TBL] [Abstract][Full Text] [Related]
29. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):213-9. PubMed ID: 14973105
[TBL] [Abstract][Full Text] [Related]
30. Local duplication of gonadotropin-releasing hormone (GnRH) receptor before two rounds of whole genome duplication and origin of the mammalian GnRH receptor.
Sefideh FA; Moon MJ; Yun S; Hong SI; Hwang JI; Seong JY
PLoS One; 2014; 9(2):e87901. PubMed ID: 24498396
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms of caprine GnRHR gene and their association with litter size in West African Dwarf goats.
Bemji MN; Isa AM; Ibeagha-Awemu EM; Wheto M
Mol Biol Rep; 2018 Feb; 45(1):63-69. PubMed ID: 29288425
[TBL] [Abstract][Full Text] [Related]
32. Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies.
Feigelson HS; Cox DG; Cann HM; Wacholder S; Kaaks R; Henderson BE; Albanes D; Altshuler D; Berglund G; Berrino F; Bingham S; Buring JE; Burtt NP; Calle EE; Chanock SJ; Clavel-Chapelon F; Colditz G; Diver WR; Freedman ML; Haiman CA; Hankinson SE; Hayes RB; Hirschhorn JN; Hunter D; Kolonel LN; Kraft P; LeMarchand L; Linseisen J; Modi W; Navarro C; Peeters PH; Pike MC; Riboli E; Setiawan VW; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D
Cancer Res; 2006 Feb; 66(4):2468-75. PubMed ID: 16489054
[TBL] [Abstract][Full Text] [Related]
33. PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).
Dossus L; Kaaks R; Canzian F; Albanes D; Berndt SI; Boeing H; Buring J; Chanock SJ; Clavel-Chapelon F; Feigelson HS; Gaziano JM; Giovannucci E; Gonzalez C; Haiman CA; Hallmans G; Hankinson SE; Hayes RB; Henderson BE; Hoover RN; Hunter DJ; Khaw KT; Kolonel LN; Kraft P; Ma J; Le Marchand L; Lund E; Peeters PH; Stampfer M; Stram DO; Thomas G; Thun MJ; Tjonneland A; Trichopoulos D; Tumino R; Riboli E; Virtamo J; Weinstein SJ; Yeager M; Ziegler RG; Cox DG
Carcinogenesis; 2010 Mar; 31(3):455-61. PubMed ID: 19965896
[TBL] [Abstract][Full Text] [Related]
34. Common genetic variation in the 3'-untranslated region of gonadotropin-releasing hormone receptor regulates gene expression in cella and is associated with thyroid function, insulin secretion as well as insulin sensitivity in polycystic ovary syndrome patients.
Li Q; Yang G; Wang Y; Zhang X; Sang Q; Wang H; Zhao X; Xing Q; He L; Wang L
Hum Genet; 2011 May; 129(5):553-61. PubMed ID: 21274726
[TBL] [Abstract][Full Text] [Related]
35. Effect of GnRHR polymorphisms on in vitro fertilization and embryo transfer in patients with polycystic ovary syndrome.
Chen WY; Du YQ; Guan X; Zhang HY; Liu T
J Hum Genet; 2017 Dec; 62(12):1065-1071. PubMed ID: 28878336
[TBL] [Abstract][Full Text] [Related]
36. Common genetic variation at PTEN and risk of sporadic breast and prostate cancer.
Haiman CA; Stram DO; Cheng I; Giorgi EE; Pooler L; Penney K; Le Marchand L; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):1021-5. PubMed ID: 16702386
[TBL] [Abstract][Full Text] [Related]
37. Choosing haplotype-tagging SNPS based on unphased genotype data using a preliminary sample of unrelated subjects with an example from the Multiethnic Cohort Study.
Stram DO; Haiman CA; Hirschhorn JN; Altshuler D; Kolonel LN; Henderson BE; Pike MC
Hum Hered; 2003; 55(1):27-36. PubMed ID: 12890923
[TBL] [Abstract][Full Text] [Related]
38. Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States.
Maas P; Barrdahl M; Joshi AD; Auer PL; Gaudet MM; Milne RL; Schumacher FR; Anderson WF; Check D; Chattopadhyay S; Baglietto L; Berg CD; Chanock SJ; Cox DG; Figueroa JD; Gail MH; Graubard BI; Haiman CA; Hankinson SE; Hoover RN; Isaacs C; Kolonel LN; Le Marchand L; Lee IM; Lindström S; Overvad K; Romieu I; Sanchez MJ; Southey MC; Stram DO; Tumino R; VanderWeele TJ; Willett WC; Zhang S; Buring JE; Canzian F; Gapstur SM; Henderson BE; Hunter DJ; Giles GG; Prentice RL; Ziegler RG; Kraft P; Garcia-Closas M; Chatterjee N
JAMA Oncol; 2016 Oct; 2(10):1295-1302. PubMed ID: 27228256
[TBL] [Abstract][Full Text] [Related]
39. Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype-phenotype relationships.
Brioude F; Bouligand J; Trabado S; Francou B; Salenave S; Kamenicky P; Brailly-Tabard S; Chanson P; Guiochon-Mantel A; Young J
Eur J Endocrinol; 2010 May; 162(5):835-51. PubMed ID: 20207726
[TBL] [Abstract][Full Text] [Related]
40. The prevalence of intragenic deletions in patients with idiopathic hypogonadotropic hypogonadism and Kallmann syndrome.
Pedersen-White JR; Chorich LP; Bick DP; Sherins RJ; Layman LC
Mol Hum Reprod; 2008 Jun; 14(6):367-70. PubMed ID: 18463157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
